Correction to: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma (Oncogene, (2021), 40, 2, (334-344), 10.1038/s41388-020-01529-z)

Ihab Abd-Elrahman; Taher Nassar; Noha Khairi; Riki Perlman; Simon Benita; Dina Ben Yehuda

doi:10.1038/s41388-025-03282-7

Correction to: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma (Oncogene, (2021), 40, 2, (334-344), 10.1038/s41388-020-01529-z)

Ihab Abd-Elrahman, Taher Nassar, Noha Khairi, Riki Perlman, Simon Benita, Dina Ben Yehuda

School of Pharmacy

The Hebrew University of Jerusalem

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Oncogenehttps://doi.org/10.1038/s41388-020-01529-z, published online 30 October 2020 In this article the affiliation ‘3 Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel’ for Author Noha Khairi was missing. The original article has been corrected.

Original language	English
Journal	Oncogene
DOIs	https://doi.org/10.1038/s41388-025-03282-7
State	Accepted/In press - 2025

All Science Journal Classification (ASJC) codes

Genetics
Molecular Biology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41388-025-03282-7

Cite this

@article{2ed29149c68d4aa3a5820fca34e481c0,

title = "Correction to: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma (Oncogene, (2021), 40, 2, (334-344), 10.1038/s41388-020-01529-z)",

abstract = "Correction to: Oncogenehttps://doi.org/10.1038/s41388-020-01529-z, published online 30 October 2020 In this article the affiliation {\textquoteleft}3 Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel{\textquoteright} for Author Noha Khairi was missing. The original article has been corrected.",

author = "Ihab Abd-Elrahman and Taher Nassar and Noha Khairi and Riki Perlman and Simon Benita and Yehuda, {Dina Ben}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Limited 2025.",

year = "2025",

doi = "10.1038/s41388-025-03282-7",

language = "الإنجليزيّة",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Correction to

T2 - Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma (Oncogene, (2021), 40, 2, (334-344), 10.1038/s41388-020-01529-z)

AU - Abd-Elrahman, Ihab

AU - Nassar, Taher

AU - Khairi, Noha

AU - Perlman, Riki

AU - Benita, Simon

AU - Yehuda, Dina Ben

PY - 2025

Y1 - 2025

N2 - Correction to: Oncogenehttps://doi.org/10.1038/s41388-020-01529-z, published online 30 October 2020 In this article the affiliation ‘3 Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel’ for Author Noha Khairi was missing. The original article has been corrected.

AB - Correction to: Oncogenehttps://doi.org/10.1038/s41388-020-01529-z, published online 30 October 2020 In this article the affiliation ‘3 Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel’ for Author Noha Khairi was missing. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85217566875&partnerID=8YFLogxK

U2 - 10.1038/s41388-025-03282-7

DO - 10.1038/s41388-025-03282-7

M3 - تعليقَ / نقاش

C2 - 39881016

SN - 0950-9232

JO - Oncogene

JF - Oncogene

ER -

Correction to: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma (Oncogene, (2021), 40, 2, (334-344), 10.1038/s41388-020-01529-z)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this